A Cost-Utility Analysis of Prosigna®, A 50 Gene Test for Predicting Breast Cancer Recurrence, in the Australian Setting
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI